Evidence map›Paper›PMID 26376694›Full record

ArticleTechnology in cancer research & treatment2016

Evaluation of Dynamic Optical Projection of Acquired Luminescence for Sentinel Lymph Node Biopsy in Large Animals.

Elizabeth Ringhausen, Tylon Wang, Jonathan Pitts, Pinaki Sarder, Walter J Akers

Open access · bronzeAbstract read
In one paragraph

Article in Technology in cancer research & treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elizabeth RinghausenMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Tylon WangMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Jonathan PittsMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Pinaki SarderDepartment of Pathology and Anatomical Sciences, University at Buffalo, Buffalo, NY, USA.
Walter J AkersMallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA akersw@mir.wustl.edu.
Mallinckrodt (United States) · USUniversity at Buffalo, State University of New York · US

Funding

MULTIMODAL PRECLINICAL CANCER IMAGING AND THERAPY RESEARCH SPECIALISTR50CA211481 · NCI · WASHINGTON UNIVERSITY · PI AKERS, WALTER JOHN · 2016 to 2020
$841k
Quantitative Optical Imaging of Molecular Processes in Preclinical Cancer ModelsK01OD010935 · OD · WASHINGTON UNIVERSITY · PI AKERS, WALTER JOHN · 2012 to 2014
$361k
Quantitative Optical Imaging of Molecular Processes in Preclinical Cancer ModelsK01RR026095 · NCRR · WASHINGTON UNIVERSITY · PI AKERS, WALTER JOHN · 2010 to 2011
$245k
NCI NIH HHS R50 CA211481NCRR NIH HHS K01 RR026095NIH HHS K01 OD010935
6 · The paper itself

Abstract

Open surgery requiring cytoreduction still remains the primary treatment course for many cancers. The extent of resection is vital for the outcome of surgery, greatly affecting patients' follow-up treatment including need for revision surgery in the case of positive margins, choice of chemotherapy, and overall survival. Existing imaging modalities such as computed tomography, magnetic resonance imaging, and positron emission tomography are useful in the diagnostic stage and long-term monitoring but do not provide the level of temporal or spatial resolution needed for intraoperative surgical guidance. Surgeons must instead rely on visual evaluation and palpation in order to distinguish tumors from surrounding tissues. Fluorescence imaging provides high-resolution, real-time mapping with the use of a contrast agent and can greatly enhance intraoperative imaging. Here we demonstrate an intraoperative, real-time fluorescence imaging system for direct highlighting of target tissues for surgical guidance, optical projection of acquired luminescence (OPAL). Image alignment, accuracy, and resolution was determined in vitro prior to demonstration of feasibility for operating room use in large animal models of sentinel lymph node biopsy. Fluorescence identification of regional lymph nodes after intradermal injection of indocyanine green was performed in pigs with surgical guidance from the OPAL system. Acquired fluorescence images were processed and rapidly reprojected to highlight indocyanine green within the true surgical field. OPAL produced enhanced visualization for resection of lymph nodes at each anatomical location. Results show the optical projection of acquired luminescence system can successfully use fluorescence image capture and projection to provide aligned image data that is invisible to the human eye in the operating room setting.

Indexed as

AnimalsFemaleFluorescenceFluorescent DyesIndocyanine GreenLuminescenceLymphatic MetastasisOptical ImagingPositron-Emission TomographySentinel Lymph NodeSentinel Lymph Node BiopsySwineTomography, X-Ray ComputedFluorescent DyesIndocyanine Greencancerfluorescenceimagingindocyanine greenmarginsoncologyprojectionsurgery

Identifiers

PMID26376694
PMCPMC4862947
OpenAlexW2256709272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.